Copyright Reports & Markets. All rights reserved.

Global Bronchiectasis Drugs Market Size, Status and Forecast 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered
    • 1.4 Market Analysis by Type
      • 1.4.1 Global Bronchiectasis Drugs Market Size Growth Rate by Type (2014-2025)
      • 1.4.2 Antibiotics
      • 1.4.3 Expectorants
      • 1.4.4 Other drugs
    • 1.5 Market by Application
      • 1.5.1 Global Bronchiectasis Drugs Market Share by Application (2019-2025)
      • 1.5.2 Hospital
      • 1.5.3 Research institute
      • 1.5.4 Clinic
      • 1.5.5 Other
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends

    • 2.1 Bronchiectasis Drugs Market Size
    • 2.2 Bronchiectasis Drugs Growth Trends by Regions
      • 2.2.1 Bronchiectasis Drugs Market Size by Regions (2019-2025)
      • 2.2.2 Bronchiectasis Drugs Market Share by Regions (2014-2019)
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Challenges
      • 2.3.4 Porter’s Five Forces Analysis

    3 Market Share by Key Players

    • 3.1 Bronchiectasis Drugs Market Size by by Players
      • 3.1.1 Global Bronchiectasis Drugs Revenue by by Players (2014-2019)
      • 3.1.2 Global Bronchiectasis Drugs Revenue Market Share by by Players (2014-2019)
      • 3.1.3 Global Bronchiectasis Drugs Market Concentration Ratio (CR5 and HHI)
    • 3.2 Bronchiectasis Drugs Key Players Head office and Area Served
    • 3.3 Key Players Bronchiectasis Drugs Product/Solution/Service
    • 3.4 Date of Enter into Bronchiectasis Drugs Market
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type and Application

    • 4.1 Global Bronchiectasis Drugs Market Size by Type (2014-2019)
    • 4.2 Global Bronchiectasis Drugs Market Size by Application (2014-2019)

    5 North America

    • 5.1 North America Bronchiectasis Drugs Market Size (2014-2019)
    • 5.2 Bronchiectasis Drugs Key Players in North America
    • 5.3 North America Bronchiectasis Drugs Market Size by Type
    • 5.4 North America Bronchiectasis Drugs Market Size by Application

    6 Europe

    • 6.1 Europe Bronchiectasis Drugs Market Size (2014-2019)
    • 6.2 Bronchiectasis Drugs Key Players in Europe
    • 6.3 Europe Bronchiectasis Drugs Market Size by Type
    • 6.4 Europe Bronchiectasis Drugs Market Size by Application

    7 China

    • 7.1 China Bronchiectasis Drugs Market Size (2014-2019)
    • 7.2 Bronchiectasis Drugs Key Players in China
    • 7.3 China Bronchiectasis Drugs Market Size by Type
    • 7.4 China Bronchiectasis Drugs Market Size by Application

    8 Japan

    • 8.1 Japan Bronchiectasis Drugs Market Size (2014-2019)
    • 8.2 Bronchiectasis Drugs Key Players in Japan
    • 8.3 Japan Bronchiectasis Drugs Market Size by Type
    • 8.4 Japan Bronchiectasis Drugs Market Size by Application

    9 Southeast Asia

    • 9.1 Southeast Asia Bronchiectasis Drugs Market Size (2014-2019)
    • 9.2 Bronchiectasis Drugs Key Players in Southeast Asia
    • 9.3 Southeast Asia Bronchiectasis Drugs Market Size by Type
    • 9.4 Southeast Asia Bronchiectasis Drugs Market Size by Application

    10 India

    • 10.1 India Bronchiectasis Drugs Market Size (2014-2019)
    • 10.2 Bronchiectasis Drugs Key Players in India
    • 10.3 India Bronchiectasis Drugs Market Size by Type
    • 10.4 India Bronchiectasis Drugs Market Size by Application

    11 Central & South America

    • 11.1 Central & South America Bronchiectasis Drugs Market Size (2014-2019)
    • 11.2 Bronchiectasis Drugs Key Players in Central & South America
    • 11.3 Central & South America Bronchiectasis Drugs Market Size by Type
    • 11.4 Central & South America Bronchiectasis Drugs Market Size by Application

    12 International Players Profiles

    • 12.1 Endo International Plc
      • 12.1.1 Endo International Plc Company Details
      • 12.1.2 Company Description and Business Overview
      • 12.1.3 Bronchiectasis Drugs Introduction
      • 12.1.4 Endo International Plc Revenue in Bronchiectasis Drugs Business (2014-2019))
      • 12.1.5 Endo International Plc Recent Development
    • 12.2 GlaxoSmithKline Plc
      • 12.2.1 GlaxoSmithKline Plc Company Details
      • 12.2.2 Company Description and Business Overview
      • 12.2.3 Bronchiectasis Drugs Introduction
      • 12.2.4 GlaxoSmithKline Plc Revenue in Bronchiectasis Drugs Business (2014-2019)
      • 12.2.5 GlaxoSmithKline Plc Recent Development
    • 12.3 Neopharma LLC
      • 12.3.1 Neopharma LLC Company Details
      • 12.3.2 Company Description and Business Overview
      • 12.3.3 Bronchiectasis Drugs Introduction
      • 12.3.4 Neopharma LLC Revenue in Bronchiectasis Drugs Business (2014-2019)
      • 12.3.5 Neopharma LLC Recent Development
    • 12.4 Pfizer Inc.
      • 12.4.1 Pfizer Inc. Company Details
      • 12.4.2 Company Description and Business Overview
      • 12.4.3 Bronchiectasis Drugs Introduction
      • 12.4.4 Pfizer Inc. Revenue in Bronchiectasis Drugs Business (2014-2019)
      • 12.4.5 Pfizer Inc. Recent Development
    • 12.5 Reckitt Benckiser Group Plc
      • 12.5.1 Reckitt Benckiser Group Plc Company Details
      • 12.5.2 Company Description and Business Overview
      • 12.5.3 Bronchiectasis Drugs Introduction
      • 12.5.4 Reckitt Benckiser Group Plc Revenue in Bronchiectasis Drugs Business (2014-2019)
      • 12.5.5 Reckitt Benckiser Group Plc Recent Development

    13 Market Forecast 2019-2025

    • 13.1 Market Size Forecast by Product (2019-2025)
    • 13.2 Market Size Forecast by Application (2019-2025)
    • 13.3 Market Size Forecast by Regions
    • 13.4 North America
    • 13.5 Europe
    • 13.6 China
    • 13.7 Japan
    • 13.8 Southeast Asia
    • 13.9 India
    • 13.10 Central & South America

    14 Analyst's Viewpoints/Conclusions

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
          • 15.1.1.1 Research Programs/Design
          • 15.1.1.2 Market Size Estimation
          • 15.1.1.3 Market Breakdown and Data Triangulation
        • 15.1.2 Data Source
          • 15.1.2.1 Secondary Sources
          • 15.1.2.2 Primary Sources
      • 15.2 Disclaimer

      Diagnosis methods of bacterial lung infections have several limitations, including failure to precisely recognize the cause of infection and inability to provide a full representation of the bacterial load present in the lungs. This has driven researchers to develop a new probe, which can detect bacteria in the lungs efficiently.
      The use of this probe will also help in identifying the exact causing agent of bronchiectasis. The high-resolution computed tomography (HRCT) scan has also emerged as a popular diagnostic technique for screening bronchiectasis and other respiratory diseases. Such advances in the diagnostics of respiratory diseases will enable pulmonologists and otolaryngologists to precisely identify the stage of the disease and provide appropriate and timely treatment to patients.
      In 2018, the global Bronchiectasis Drugs market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

      This report focuses on the global Bronchiectasis Drugs status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Bronchiectasis Drugs development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

      The key players covered in this study
      Endo International Plc
      GlaxoSmithKline Plc
      Neopharma LLC
      Pfizer Inc.
      Reckitt Benckiser Group Plc
      ...

      Market segment by Type, the product can be split into
      Antibiotics
      Expectorants
      Other drugs

      Market segment by Application, split into
      Hospital
      Research institute
      Clinic
      Other

      Market segment by Regions/Countries, this report covers
      North America
      Europe
      China
      Japan
      Southeast Asia
      India
      Central & South America

      The study objectives of this report are:
      To analyze global Bronchiectasis Drugs status, future forecast, growth opportunity, key market and key players.
      To present the Bronchiectasis Drugs development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
      To strategically profile the key players and comprehensively analyze their development plan and strategies.
      To define, describe and forecast the market by product type, market and key regions.

      In this study, the years considered to estimate the market size of Bronchiectasis Drugs are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025
      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
      Buy now